A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML
Clinical trial NCT03280030 · COMPLETED
Trial details
- NCT number
- NCT03280030
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-06
- Primary completion
- 2022-11-14
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.